TETRA Technologies, Inc. - Q1 2008 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2008. TETRA Technologies, Inc. is an oil and gas services and production company with integrated manufacturing operations. The company operates through four segments: Fluids, WA&D Services, Maritech (oil and gas production), and Production Enhancement. The company is a large accelerated filer.
Key Financial Metrics
| Metric | Q1 2008 | Q1 2007 |
|---|---|---|
| Total Revenues | $225.2 million | $243.6 million |
| Gross Profit | $42.0 million | $57.5 million |
| Gross Margin | 18.7% | 23.6% |
| Operating Income | $16.9 million | $33.9 million |
| Net Income | $6.7 million | $20.7 million |
| Diluted EPS | $0.09 | $0.28 |
| Operating Cash Flow | $46.6 million | $74.8 million |
| Long-Term Debt | $361.8 million | $358.0 million |
| Cash & Equivalents | $0.2 million | $21.8 million (Dec 31, 2007) |
Material Changes vs. Prior Period
- Revenue Decline: Consolidated revenues decreased 7.6% year-over-year. The WA&D Services segment saw a 42.4% revenue drop due to weather disruptions and reduced heavy lift capacity. Conversely, the Production Enhancement Division grew 33.9% and Maritech grew 16.7%.
- Profitability Compression: Net income fell 68% to $6.7 million. Gross margins contracted from 23.6% to 18.7% driven by increased operating costs in Maritech and lower margins in the Fluids Division.
- Segment Performance:
- WA&D Services: Reported a pre-tax loss of $4.1 million compared to $11.0 million profit in Q1 2007, primarily due to weather-related project postponements.
- Maritech: Revenues increased due to higher production volumes and commodity prices, but pre-tax income dropped 33.7% due to a $10.5 million increase in operating expenses (including depreciation and decommissioning costs).
- Production Enhancement: Remained the strongest performer with a 34.1% increase in pre-tax income to $15.4 million.
- Liquidity: Cash and cash equivalents dropped significantly from $21.8 million at year-end 2007 to $0.2 million at March 31, 2008, due to heavy capital expenditures ($67.3 million) and working capital changes.
Guidance, Outlook, and Risks
- Capital Expenditures: The company plans to expend over $300 million in capital expenditures during 2008, including the development of a new Arkansas calcium chloride plant ($103 million) and a new corporate headquarters ($39 million).
- Financing: In April 2008 (subsequent to period end), the company issued $125 million in Senior Notes to pay down its revolving credit facility, increasing available borrowing capacity to approximately $212 million.
- Outlook: Management expects strong demand for products and services to continue throughout 2008. However, profitability may be impacted by increased costs and capacity constraints.
- Legal & Contingencies:
- Class Action Lawsuits: Two putative class action complaints were filed in March/April 2008 alleging securities law violations. Management intends to vigorously defend these actions.
- Insurance Litigation: Ongoing dispute with insurers regarding coverage for Hurricane Katrina/Rita damage to Maritech assets. The outcome could significantly impact future operating cash flow.
- Decommissioning Obligations: Maritech holds a significant decommissioning liability (undiscounted value approx. $299.4 million), which is subject to estimation risks and potential insurance recoveries.
Investor Verification Checklist
- Cash Position: Verify the impact of the April 2008 debt issuance on the current cash balance and liquidity ratios, given the near-zero cash balance at quarter-end.
- WA&D Weather Impact: Assess the extent to which Q1 weather disruptions were temporary versus indicative of longer-term capacity or demand issues in the Gulf of Mexico.
- Insurance Recovery: Monitor the status of the lawsuit against insurers regarding Hurricane damage, as a favorable resolution could materially improve cash flows.
- Decommissioning Costs: Review the assumptions used for Maritech's decommissioning liabilities and the likelihood of insurance reimbursements for well intervention costs.
- Capital Allocation: Evaluate the return on investment for the planned $300+ million capital expenditure program, particularly the new Arkansas plant and Maritech development.